Gritstone Oncology (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 20, 2015
- Vertical
- Cancer Immunotherapy
- Funding URL
- View Funding Page
- Funding Amount:
- $102,000,000
Company Info
- Company Description
- Gritstone Oncology is a privately-held cancer immunotherapy company developing next-generation personalized cancer therapeutics. Gritstone brings together distinguished scientific founders, an experienced and diverse management team, a seasoned and successful board of directors, and deep financial backing to tackle fundamental challenges at the intersection of cancer genomics, immunology, and immunotherapy design.
- Market
- Lung Cancer Treatment
- Location
- San Francisco, CA, USA
- Coinvestors
- Casdin Capital, Clarus Ventures, Frazier Healthcare, Redmile Group, The Column Group, Transformational Healthcare Opportunity, Versant Ventures